Stage III Cutaneous Melanoma AJCC v7

Drug Trials

Drug	Drug Name	Drug Description

Drug	Drug Name	Target	Type

Drug	Drug Name	Phase	Status	Count
DB08912	Dabrafenib	1	Active Not Recruiting	1
DB08912	Dabrafenib	1	Recruiting	1
DB06186	Ipilimumab	1	Active Not Recruiting	1
DB06186	Ipilimumab	1	Recruiting	1
DB09035	Nivolumab	1	Active Not Recruiting	1
DB09035	Nivolumab	1	Recruiting	1
DB06306	Onalespib	1	Recruiting	1
DB00740	Riluzole	1	Active Not Recruiting	1
DB06176	Romidepsin	1	Recruiting	1
DB00398	Sorafenib	1	Active Not Recruiting	1
DB08911	Trametinib	1	Active Not Recruiting	1
DB08911	Trametinib	1	Recruiting	1
DB08912	Dabrafenib	1 / 2	Recruiting	1
DB05996	Glembatumumab vedotin	1 / 2	Withdrawn	1
DB06186	Ipilimumab	1 / 2	Recruiting	1
DB06186	Ipilimumab	1 / 2	Withdrawn	1
DB12340	Navitoclax	1 / 2	Recruiting	1
DB09035	Nivolumab	1 / 2	Recruiting	1
DB09035	Nivolumab	1 / 2	Withdrawn	1
DB09037	Pembrolizumab	1 / 2	Recruiting	1
DB08911	Trametinib	1 / 2	Recruiting	1
DB00945	Acetylsalicylic acid	2	Recruiting	1
DB08885	Aflibercept	2	Completed	1
DB00041	Aldesleukin	2	Completed	1
DB11791	Capmatinib	2	Recruiting	1
DB09063	Ceritinib	2	Recruiting	1
DB08912	Dabrafenib	2	Recruiting	2
DB11986	Entrectinib	2	Recruiting	1
DB06186	Ipilimumab	2	Active Not Recruiting	1
DB06186	Ipilimumab	2	Recruiting	2
DB09035	Nivolumab	2	Recruiting	2
DB09037	Pembrolizumab	2	Recruiting	2
DB08896	Regorafenib	2	Recruiting	1
DB00020	Sargramostim	2	Active Not Recruiting	1
DB13896	Talimogene laherparepvec	2	Recruiting	1
DB08911	Trametinib	2	Recruiting	2
DB06186	Ipilimumab	2 / 3	Suspended	1
DB09035	Nivolumab	2 / 3	Suspended	1
DB00020	Sargramostim	2 / 3	Suspended	1
DB08912	Dabrafenib	3	Recruiting	1
DB00105	Interferon alfa-2b	3	Active Not Recruiting	1
DB06186	Ipilimumab	3	Active Not Recruiting	1
DB06186	Ipilimumab	3	Recruiting	1
DB09035	Nivolumab	3	Recruiting	1
DB09037	Pembrolizumab	3	Active Not Recruiting	1
DB08911	Trametinib	3	Recruiting	1